Laboratory Centrifuge Global Market Report 2024

The laboratory centrifuge market size has grown strongly in recent years. It will grow from $1.53 billion in 2023 to $1.61 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth observed in the historic period can be attributed to various factors, including contributions to scientific discoveries, utilization for academic and educational purposes, historical advancements in healthcare infrastructure, roles in blood banking and transfusion medicine, as well as industrial and pharmaceutical applications.

The laboratory centrifuge market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth in the forecast period can be credited to the integration of data analytics, increased adoption of point-of-care testing, a surge in investments in life sciences, a heightened focus on bioprocessing and biopharmaceuticals, and a notable shift towards personalized medicine. Key trends expected in the forecast period encompass a heightened emphasis on user experience, greater adoption of disposable technologies, increased emphasis on remote monitoring and connectivity, the incorporation of safety features, as well as an increased focus on customization and modularity.

The laboratory centrifuge market is experiencing growth propelled by the emergence of infectious diseases. Diseases such as SARS, Zika virus, Ebola, and COVID-19 have led to increased infections globally, contributing to a rise in the overall disease burden. Approximately 60% of known human pathogens and up to 75% of emerging human pathogens are zoonotic infectious agents, representing diseases that evolve from animals to infect humans. The evolving climate, a result of climate change, is anticipated to impact the epidemiology of infectious diseases by altering microbial and vector geographic ranges. Microbes can adapt to higher temperatures, raising concerns that global warming may favor microbes with increased heat tolerance, potentially introducing new infectious diseases and altering the epidemiology of existing ones. Laboratory centrifuge systems play a crucial role in various applications, including cell, organelle, virus, protein, and nucleic acid purification. Consequently, the demand for lab testing solutions driven by the emergence of infectious diseases contributes to the growth of the laboratory centrifuge market.

The increasing prevalence of chronic diseases is poised to drive the growth of the laboratory centrifuge market in the foreseeable future. Chronic diseases are characterized by persistent and often progressive symptoms, necessitating continuous management and care. Laboratory centrifuges play a crucial role in separating blood components for diagnostic testing related to chronic diseases, aiding in disease identification and management. As of January 2023, a report from the National Institutes of Health (NIH) projected a 99.5% increase in the number of individuals aged 50 and older with at least one chronic illness, from 71.522 million in 2020 to 142.66 million in 2050. This underscores how the growing prevalence of chronic diseases is a key driver for the laboratory centrifuge market.

Technological advancements emerge as a prominent trend in the laboratory centrifuge market. Companies within the market are dedicated to enhancing and refining devices with improved workflows. In 2021, the German life science company Eppendorf introduced the Centrifuge 5910 Ri, a new centrifuge aimed at enhancing laboratory efficiency. This innovative device provides scientists with advanced features, streamlining and expediting centrifugation steps in their workflows, and also offers the capability of remote monitoring.

Leading companies in the laboratory centrifuge market are placing a strong emphasis on the development of versatile centrifuge models, such as refrigerated benchtop centrifuges, to address evolving laboratory requirements and gain a competitive edge in the market. A refrigerated benchtop centrifuge is a compact laboratory instrument with built-in cooling capabilities that utilizes centrifugal force to separate and process samples at controlled temperatures. For example, in February 2022, Beckman Coulter Life Sciences, a provider of research and clinical diagnostic laboratory solutions based in the United States, introduced the Allegra V-15R refrigerated benchtop centrifuge. This versatile model, 28% smaller than comparable units, provides 10 rotor configurations and 50 programmable runs, accommodating diverse workflows from cell separation to high-throughput screening. Safety enhancements include Automatic Rotor Recognition and BioSafe rotors with hermetic seals. With a gravitational force of up to 20,412 x g and speeds of 13,500 rpm, the Allegra V-15R ensures efficient and quiet lab operations (≤55 dBA). Noteworthy features include temperature control, an ergonomic design, and an extensive rotor portfolio catering to varied research needs.

In April 2021, Trucent, a U.S.-based provider of advanced centrifuge technologies and services, completed the acquisition of Separator Restorations for an undisclosed sum. The objective of this acquisition was to broaden Trucent's capabilities in centrifuge services, strengthen the Centrifuge Parts and Repair (CPR) business, and leverage Separator Restorations' nearly 40 years of expertise to reinforce Trucent's market position. Separator Restorations, also based in the U.S., specializes in servicing, repairing, remanufacturing, and supplying parts for centrifuges from well-known brands.

Major companies operating in the laboratory centrifuge market report are Panasonic Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Corning Inc., Agilent Technologies Inc., Olympus Corporation, Sartorius AG, PerkinElmer Inc., Shimadzu Corporation, Bio-Rad Laboratories Inc., Hettich Holding GmbH & Co. KG, Eppendorf AG, Haier Biomedical Co. Ltd., Heal Force Bio-Medical Engineering Co. Ltd., Nuaire Limited, Harvard Bioscience Inc., REMI GROUP, Narang Medical Limited, Andreas Hettich GmbH & Co. KG, VISION Scientific Co. Ltd., LW Scientific, Sigma Laborzentrifugen GmbH, Benchmark Scientific Inc., Neuation Technologies Pvt. Ltd., Laby Instruments Industry, HERMLE Labortechnik GmbH, Antylia Scientific Instrument Co. Ltd., Meditech Technologies India Private Limited.

North America was the largest region in the laboratory centrifuge market in 2023. The regions covered in the laboratory centrifuge market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the laboratory centrifuge market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products within laboratory centrifuges encompass both equipment and accessories. This equipment is employed for the separation of serum or plasma from red blood cells, isolating precipitated solids from the liquid phase in a mixture, and distinguishing liquids with different densities. The models of laboratory centrifuges include benchtop and floor-standing varieties. Various rotor designs, such as fixed-angle, swinging-bucket, vertical, and others, contribute to their versatility. Laboratory centrifuges find applications in diagnostics, microbiology, cellomics, genomics, proteomics, blood component separation, and more. Their users span hospitals, biotechnology and pharmaceutical companies, as well as academic and research institutions.

The laboratory centrifuge market research report is one of a series of new reports that provides laboratory centrifuge market statistics, including laboratory centrifuge industry global market size, regional shares, competitors with laboratory centrifuge market share, detailed laboratory centrifuge market segments, market trends and opportunities, and any further data you may need to thrive in the laboratory centrifuge industry. This laboratory centrifuge market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The laboratory centrifuge market system consists of sales of microcentrifuge, refrigerated centrifuge, high-speed refrigerated centrifuge, and ultracentrifuge. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.